1347 Capital Corp stock reaches all-time high at 143.11 USD

1347 Capital Corp stock has reached an all-time high, hitting a price of 143.11 USD. According to InvestingPro data, the company’s market capitalization now stands at $1.65 billion, with the stock trading significantly above its 52-week low of $48.17. This milestone reflects a substantial increase, as the company’s stock has experienced a remarkable 148.54% change over the past year. The surge in stock price underscores significant investor confidence and interest in 1347 Capital Corp, marking a noteworthy period of growth for the company. With a P/E ratio of 47.5x and an EBITDA of $56.8 million for the last twelve months, InvestingPro analysis indicates the stock appears overvalued at current levels. The company maintains strong fundamentals with a current ratio of 1.55 and operates with moderate debt levels, though investors should note that multiple InvestingPro Tips suggest elevated valuation metrics.

In other recent news, Limbach Holdings (NASDAQ:LMB) reported strong financial results for the first quarter of 2025, with earnings per share (EPS) of $1.12, significantly surpassing the forecasted $0.43. The company achieved revenue of $133.1 million, exceeding the expected $120.48 million, driven by a robust performance in its Owner Direct Revenue (ODR) segment, which grew by 22% year-over-year. The adjusted EBITDA for the quarter was $15 million, outperforming the consensus projection of $10 million, with a margin of 11.2%, marking a notable improvement from the previous year. Limbach Holdings also updated its forecast for free cash flow conversion, now expecting approximately 75% of its adjusted EBITDA to convert to free cash flow, an increase from the previously estimated 70%.

Additionally, Stifel analysts maintained their Buy rating for Limbach Holdings with a price target of $103.00, citing the company’s strategic transformation and potential for further margin improvements. They noted opportunities for larger capital programs, particularly in the healthcare sector, due to aging infrastructure in U.S. healthcare facilities. During Limbach’s annual meeting, shareholders approved several key decisions, including the election of directors and amendments to the company’s Omnibus Incentive Plan. The amendment includes provisions for the acceleration of vesting of restricted stock units (RSUs) and performance-based stock units (PSUs) under specific conditions.

Furthermore, the appointment of Crowe LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Stifel analysts emphasized Limbach’s strategic initiatives, noting the company’s potential for substantial growth in the coming years, particularly in expanding its offerings and improving gross margins. These developments highlight Limbach Holdings’ continued focus on strategic growth and operational efficiency.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.